Irwin Naturals aims to grow into the largest chain of psychedelic-assisted mental health clinics in the country, the report said.
“By leveraging our status as the first household brand, our profitable core business, and our ability to realize economies of scale to reduce patient acquisition costs, we anticipate being able to bring this life-changing treatment to the masses who need it across all of the U.S. and beyond,” CEO Klee Irwin told Benzinga.
No dollar amount was disclosed, but the transaction is being made with cash and company stock, the report said.
